Sara Aiman

Dr. Sara Aiman

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
SKSehrish kakakhel
Sehrish kakakhel
AAAbbas Ahmad
Abbas Ahmad
WMWael Ali Mahdi
Wael Ali Mahdi
SASultan Alshehri
Sultan Alshehri
SASara Aiman
Sara Aiman
AKAsifullah Khan
Asifullah Khan
Lumpy skin disease is a fatal emerging disease of cattle, which has started to gain extensive attention due to its rapid incursions across the globe. The disease epidemic causes economic loss and cattle morbidity. Currently, there are no specific treatments and safe vaccines against the lumpy skin disease virus (LSDV) to halt the spread of the disease. The current study uses genome-scan vaccinomics analyses to prioritize promiscuous vaccine candidate proteins of the LSDV. These proteins were subjected to top-ranked B- and T-cell epitope prediction based on their antigenicity, allergenicity, and toxicity values. The shortlisted epitopes were connected using appropriate linkers and adjuvant sequences to design multi-epitope vaccine constructs. Three vaccine constructs were prioritized based on their immunological and physicochemical properties. The model constructs were back-translated to nucleotide sequences and codons were optimized. The Kozak sequence with a start codon along with MITD, tPA, Goblin 5′, 3′ UTRs, and a poly(A) tail sequences were added to design a stable and highly immunogenic mRNA vaccine. Molecular docking followed by MD simulation analysis predicted significant binding affinity and stability of LSDV-V2 construct within bovine immune receptors and predicted it to be the top-ranked candidate to stimulate the humeral and cellular immunogenic responses. Furthermore, in silico restriction cloning predicted feasible gene expression of the LSDV-V2 construct in a bacterial expression vector. It could prove worthwhile to validate the predicted vaccine models experimentally and clinically against LSDV.

16 November 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
SBSara Begum
Sara Begum
SASara Aiman
Sara Aiman
SAShujaat Ahmad
Shujaat Ahmad
ASAbdus Samad
Abdus Samad
MAMazen Almehmadi
Mazen Almehmadi
AKAsifullah Khan
Asifullah Khan
Clinical epidemiological studies have reported that viral infections cause autoimmune pathology in humans. Host-pathogen protein sequences and structure-based molecular mimicry cause autoreactive T cells to cross-activate. The aim of the current study was to implement immunoinformatics approaches to infer sequence- and structure-based molecular mimicry between viral and human proteomic datasets. The protein sequences of all the so far known human-infecting viruses were obtained from the VIPR database, and complete human proteome data were retrieved from the NCBI repository. Based on a predefined, stringent threshold of comparative sequence analyses, 24 viral proteins were identified with significant sequence similarity to human proteins. PathDIP identified the enrichment of these homologous proteins in nine metabolic pathways with a p-value < 0.0001. Several viral and human mimic epitopes from these homologous proteins were predicted as strong binders of human HLA alleles, with IC50 < 50 nM. Downstream molecular docking analyses identified that lead virus-human homologous epitopes feasibly interact with HLA and TLR4 types of immune receptors. The vast majority of these top-hit homolog epitopic peptides belong to the herpes simplex and poxvirus families. These lead epitope biological sequences and 3D structural-based molecular mimicry may be promising for interpreting herpes simplex virus and poxvirus infection-mediated autoimmune disorders in humans.

16 January 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
SASara Aiman
Sara Aiman
AAA. Khuzaim Alzaharani
A. Khuzaim Alzaharani
Fawad AliFawad Ali
Fawad Ali
AKAbida Khan
Abida Khan
Mohd ImranMohd Imran
Mohd Imran
AKAsifullah Khan
Asifullah Khan
Leishmania tropica is a tropical parasite causing cutaneous leishmaniasis (CL) in humans. Leishmaniasis is a serious public health threat, affecting an estimated 350 million people in 98 countries. The global rise in antileishmanial drug resistance has triggered the need to explore novel therapeutic strategies against this parasite. In the present study, we utilized the recently available multidrug resistant L. tropica strain proteome data repository to identify alternative therapeutic drug targets based on comparative subtractive proteomic and druggability analyses. Additionally, small drug-like compounds were scanned against novel targets based on virtual screening and ADME profiling. The analysis unveiled 496 essential cellular proteins of L. tropica that were nonhomologous to the human proteome set. The druggability analyses prioritized nine parasite-specific druggable proteins essential for the parasite’s basic cellular survival, growth, and virulence. These prioritized proteins were identified to have appropriate binding pockets to anchor small drug-like compounds. Among these, UDPase and PCNA were prioritized as the top-ranked druggable proteins. The pharmacophore-based virtual screening and ADME profiling predicted MolPort-000-730-162 and MolPort-020-232-354 as the top hit drug-like compounds from the Pharmit resource to inhibit L. tropica UDPase and PCNA, respectively. The alternative drug targets and drug-like molecules predicted in the current study lay the groundwork for developing novel antileishmanial therapies.

8 August 2025 in Reviews in Medical Virology
Verified
Journal Article
Closed access
RARoman Akbar
Roman Akbar
SFShabeen Fatima
Shabeen Fatima
SRSiddiq Ur Rahman
Siddiq Ur Rahman
AMAbdul Malik
Abdul Malik
SASuhail Akhtar
Suhail Akhtar
KHKaisong Huang
Kaisong Huang


1 July 2025 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
AMAbdul Malik
Abdul Malik
AAAbbas Ahmad
Abbas Ahmad
SASara Aiman
Sara Aiman
SFSamavia Farrukh
Samavia Farrukh
SFSabiha Fatima
Sabiha Fatima
AKAzmat Ali Khan
Azmat Ali Khan